InvestorsHub Logo
Followers 237
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

Re: ziploc_1 post# 274896

Wednesday, 05/20/2020 12:38:51 PM

Wednesday, May 20, 2020 12:38:51 PM

Post# of 425931
zip...

I never realised how concerned everyone was with my health...Quite a surprise...I'm doing fine..No stents. They just used a roto-rooter to clean out the pipes..No golf for a week...Abbott has a new device for sealing off the incision in the femoral artery which is pretty neat and gets rid of one form of risk...

Back to golf in a week...

Reading up on the subject of patent obviousness..Talk about stupid..Graham which frames the obvious topic was about a new type of plow..designed to avoid stones..And this is what they are using to wreck Amarin...I guess no one involved with the AC trial understands the important issue here is not obviousness. It is Property...

Unlike the plow industry..The rules in the drug industry are determined by FDA...FDA makes all the calls and determines all issues including obviousness...Since the Marine label still specifies that whether Vascepa is effective for treating very high trigs remains to be determined..Then where can "obvious" come in..

The important point is that it was Amarin who Sheparded through the FDA's long and expensive marketing process..Amarin has earned the right to market this drug..The generics are only entitled to market the drug under the Hatch-Waxman legislation or if the Generics can invalidate Amarin' patents...And they have not met the standard in doing so..The standard being the generics must clear and convincing evidence Amarin's patents are invalid...And that does not mean Amarin must prove the patents are valid...In this case the FDA and the PTO decided Amarin's patents were valid.. Only Judge Du...decided they were not valid...An opinion arrived at by factul errors...If the court can see the evil in this situation then woe to all of us and we need to move to Russia...

":>) JL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News